Cargando…

Isoniazid-resistant tuberculosis: A problem we can no longer ignore

Giorgia Sulis and Madhukar Pai discuss the global distribution, and approaches to diagnosis and treatment, of isoniazid-resistant tuberculosis,

Detalles Bibliográficos
Autores principales:	Sulis, Giorgia, Pai, Madhukar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974036/ https://www.ncbi.nlm.nih.gov/pubmed/31961857 http://dx.doi.org/10.1371/journal.pmed.1003023

Ejemplares similares

Serial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions?
por: Pai, Madhukar, et al.
Publicado: (2007)

Racism, the public health crisis we can no longer ignore
por: Devakumar, Delan, et al.
Publicado: (2020)

Diabetes: A Cinderella Subject We Can’t Afford to Ignore
por: Chan, Juliana C. N., et al.
Publicado: (2016)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

Lives lost and disease burden related to antimicrobial resistance in the Americas can no longer be ignored
por: Undurraga, Eduardo A., et al.
Publicado: (2023)

Immunotherapy in transplanted patients: A special population that can no longer be ignored
por: Rubatto, Marco, et al.
Publicado: (2021)

Altos Labs and the quest for immortality: but can we live longer right now?
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Physician-initiated Research in Social Media. An Area That Can No Longer Be Ignored
por: Desai, Tejas
Publicado: (2020)

The Cost of Ignoring Vaccines
por: Farrenkopf, Paige M.
Publicado: (2022)

11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored
por: Pretorius, Elzette, et al.
Publicado: (2016)

Nosocomial Tuberculosis in India
por: Pai, Madhukar, et al.
Publicado: (2006)

Force is a signal that cells cannot ignore
por: Yusko, Erik C., et al.
Publicado: (2014)

Epistemic Ignorance, Poverty and the COVID-19 Pandemic
por: Timmermann, Cristian
Publicado: (2020)

New tuberculosis tools are here: Can we deliver them for maximal impact?
por: Pai, Madhukar, et al.
Publicado: (2013)

Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021)

Can we ignore changing P wave polarity?
por: Chhabra, Swati, et al.
Publicado: (2016)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

Post COVID fatigue: Can we really ignore it?
por: Sharma, Priya, et al.
Publicado: (2022)

Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis
por: Svadzian, Anita, et al.
Publicado: (2020)

Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
por: Menzies, Dick, et al.
Publicado: (2009)

Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored
por: Halstead, Scott B., et al.
Publicado: (2002)

Donot Ignore Pulmonary Hypertension Any Longer. It's Time to Deal with it!
por: Mirdamadi, Ahmad
Publicado: (2011)

A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?
por: Bigio, Jacob, et al.
Publicado: (2023)

Ignoring Nurses: Media Coverage during the COVID-19 Pandemic
por: Lynch, Julia, et al.
Publicado: (2021)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Drivers of Microbiome Biodiversity: A Review of General Rules, Feces, and Ignorance
por: Reese, Aspen T., et al.
Publicado: (2018)

Making cough count in tuberculosis care
por: Zimmer, Alexandra J., et al.
Publicado: (2022)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Behavioural responses to human‐induced change: Why fishing should not be ignored
por: Diaz Pauli, Beatriz, et al.
Publicado: (2017)

Application of artificial intelligence in digital chest radiography reading for pulmonary tuberculosis screening
por: Cao, Xue-Fang, et al.
Publicado: (2021)

To pool or not to pool: Can we ignore cross-trial variability in FMRI?
por: Chen, Gang, et al.
Publicado: (2020)

Malassezia—Can it be Ignored?
por: Thayikkannu, Ambujavalli Balakrishnan, et al.
Publicado: (2015)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Big problems are ignored in UK
Publicado: (2008)

Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis
por: MacLean, Emily, et al.
Publicado: (2019)

Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
por: Shay, David K., et al.
Publicado: (2009)

Can we prevent childhood Leukaemia?
por: Greaves, Mel, et al.
Publicado: (2021)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e0dms39h0n0mjtsoqsddkvhmo8